Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of advertisement published in today''s Newspaper viz. Business Standard (English) and Mumbai Lakshadweep (Marathi) informing about completion of dispatch of Notice of the 49th AGM (including details of e-voting facility) alongwith Annual Report for financial year 2022-23 through electronic mode. The same is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record.
15-07-2023
Bigul

Alkem Laboratories Ltd - 539523 - Business Responsibility and Sustainability Reporting (BRSR)

 Pursuant to Regulation 34(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Business Responsibility and Sustainability Report for financial year ended 31st March, 2023. The same is also available on the website of the Company at www.alkemlabs.com Kindly take the same on record.
14-07-2023
Bigul

Alkem Laboratories Ltd - 539523 - Reg. 34 (1) Annual Report.

 Please find enclosed herewith the Notice of the 49th Annual General Meeting of the Company scheduled to be held on Friday, 25th August, 2023 at 11.00 a.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM) alongwith the Annual Report for financial year 2022-2023. The same is also available on the website of the Company at www.alkemlabs.com Kindly take the same on record.
14-07-2023
Bigul

Alkem Laboratories Ltd - 539523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In terms of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, please find enclosed herewith the certificate issued by M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company for the quarter ended 30th June, 2023. Kindly take the same on record.
13-07-2023

Alkem Laboratories Q1 PAT seen up 135.1% YoY to Rs 299.7 cr: Nirmal Bang

 Net Sales are expected to increase by 10.5 percent Y-o-Y (up 1.9 percent Q-o-Q) to Rs 2,847.5 crore, according to Nirmal Bang.
12-07-2023

Alkem Laboratories forays into ophthalmology segment

 The nationwide launch of the company's ophthalmology product range ensures that patients across India have access to quality eye-care formulations at an affordable price, the company said in a statement.
06-07-2023
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Mumbai Lakshadeep (Marathi) for information regarding 49th Annual General Meeting of the Company to be held through video conferencing (VC)/ other audio visual means (OAVM). The same is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record.
05-07-2023
Bigul

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

 This is to inform you that in terms of Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 29th June, 2023 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter ended 30th June, 2023 are communicated to the Stock Exchanges.
28-06-2023
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith are the details of Analyst/ Institutional Investor/ Broker meetings to be conducted.
28-06-2023
Bigul

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, attached herewith is the details of Analyst/ Institutional Investor meeting to be conducted.
28-06-2023
Next Page
Close

Let's Open Free Demat Account